Search results
Gilead Sciences, Inc. (/ ˈ ɡ ɪ l i ə d /) is an American biopharmaceutical company headquartered in Foster City, California that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19, including ledipasvir/sofosbuvir and sofosbuvir.
Get the latest Gilead Sciences, Inc. (GILD) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
Gilead Sciences is a biopharmaceutical company that researches, develops, and sells therapies for treating HIV, hepatitis B, hepatitis C, and certain cancers.
Gilead Sciences | 619,625 followers on LinkedIn. Creating Possible | At Gilead, we set – and achieve – bold ambitions to create a healthier world for all people.
Glassdoor gives you an inside look at what it's like to work at Gilead Sciences, including salaries, reviews, office photos, and more. This is the Gilead Sciences company profile. All content is posted anonymously by employees working at Gilead Sciences.
Jul 14, 2023 · News Details. View All News. FDA Approves Veklury® (Remdesivir) for COVID-19 Treatment in Patients With Severe Renal Impairment, Including Those on Dialysis. July 14, 2023. -- Veklury is Now the First Approved Antiviral Treatment for Patients Across all Stages of Renal Disease --.
Jul 22, 2023 · Rich Pedroncelli/Associated Press. Today, a generation of expensive Gilead drugs containing the new iteration of tenofovir account for half of the market for H.I.V. treatment and prevention ...
